Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IK-595 |
Synonyms | |
Therapy Description |
IK-595 inhibits the MEK-RAF complex, which potentially results in reduced tumor cell proliferation and decreased tumor growth (Mol Cancer Res (2023) 21 (5_Supplement): PR10). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IK-595 | IK595|IK 595 | IK-595 inhibits the MEK-RAF complex, which potentially results in reduced tumor cell proliferation and decreased tumor growth (Mol Cancer Res (2023) 21 (5_Supplement): PR10). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
NRAS mutant | Advanced Solid Tumor | predicted - sensitive | IK-595 | Preclinical | Actionable | In a preclinical study, IK-595 inhibited Mek and Erk phosphorylation and decreased tumor growth in an NRAS-mutant mouse tumor model (Mol Cancer Res (2023) 21 (5_Supplement): PR10). | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06270082 | Phase I | IK-595 | Study of IK-595 in RAS- or RAF-altered Advanced Tumors | Recruiting | USA | 0 |